Owning Alere Inc (ALR) May Not Be Healthy for Your Portfolio

Page 1 of 2

Alere IncCompanies offering comprehensive patient vital sign monitoring was once a business many investors were unaware of. Ever since the (attempted?) implementation of the Affordable Healthcare Act, and the subsequent flight to cut patient claims costs, the industry began reaping a windfall. The impact of real-time patient monitoring is not only in the expectation of the member to have a higher quality of life, but also offers aggregated data to insurance providers to help predict and curb future claims risk.

This transparency into a large, and potentially expensive, data pool is worth billions to insurers, and companies like Alere Inc (NYSE:ALR) have been providing the service to the patients for the benefit of the insurer. But just like any other developing market sector, Goliaths enter in, making for tough competition.

Alere’s Connected Health

Alere Inc (NYSE:ALR) is a healthcare solutions provider offering real-time, comprehensive, vital monitoring for patients suffering from a range of chronic illnesses, including congestive heart failure, diabetes, and autoimmune diseases. Its main offering is through Alere Analytics, Alere Home Monitoring, Alere Wellbeing, and Connected Device Technologies.

The specific market for medical monitoring is relatively small, compared with the market for pharmaceuticals and implant devices. It is a $11.6 billion market in the U.S. and it shows signs of exponential growth, according to NERAC.

Of the $11 billion market for remote monitoring, Alere Inc (NYSE:ALR) accounts for approximately $615 million of the market share as of December 2012. This number has remained at that approximate level since fiscal 2010, and is showing no immediate sign of growing.

The competition

Medical device giants, such as Medtronic, Inc. (NYSE:MDT) and Honeywell International Inc. (NYSE:HON) alongside savvy smaller competitors, like ActiveCare have gleefully entered this market with great aggressiveness. Medtronic, Inc. (NYSE:MDT) is a medical device behemoth with over $16 billion in revenues, and approximately $1 billion of it coming from remote care management.

Honeywell International Inc. (NYSE:HON) has made headway into the patient monitoring industry through their HomMED division, which brought in roughly $25 million of the $36 billion in revenue for the parent company. This is a small section of the company’s overall revenue picture; the potential for it to become a game changing one for Honeywell International Inc. (NYSE:HON) is small. Analysts expect the HomMED division to bring in just $35 million next year. Because of this, investors should shy away from investing in Honeywell for the purpose of being exposed to the growing patient monitoring industry.

Medtronic offers patient monitoring for chronically ill patients as part of its overall medical device offering.  Between Medtronic, Inc. (NYSE:MDT) and Honeywell, they take just under 35% of the remote patient monitoring market. “Large vendors dominate, but half of the revenue of this market are small players with nominal global market share,” said Bruce Carlson, Publisher of Kalorama Information. “Small vendors will drive growth in the market and offer cheaper or more effective products. This is particularly true in the home care and telemedicine segment.”  This speaks volumes to where investors should seek out opportunities in this niche market segment. Medtronic may be the market leader, but investors should look at smaller companies that are gaining a foothold in this industry.

ActiveCare has snuck behind these giants and acquired contracts from insurers and state governments to provide services to over 24,000 members amounting to an annual run-rate of $16 million. It was able to do this with a proprietary platform that digests patient vital data, through which its “CareCenter” provides live, real-time care.  It also has been able to realize the importance of patient data, and translated aggregated data into savings for insurers using ActiveCare’s monitoring service for their members. Look for this company to continue its growth as management forecasted the company to be monitoring 40,000 members by year’s end.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!